Mitochondrial DNA polymorphisms associated with longevity in the Turkish population
Ozgur Guney1, Handan Ak1, Sevcan Atay1
1Ege University School of Medicine, Department of Medical Biochemistry, Izmir, Turkey.
Mitochondrion
|May 6, 2014
Summary
Mitochondrial DNA mutations are linked to aging. This study found specific mitochondrial DNA variations associated with longevity in the Turkish population, suggesting a role in aging processes.
Area of Science:
- Genetics
- Gerontology
- Molecular Biology
Background:
- Mitochondrial DNA (mtDNA) mutations are implicated in aging and age-related diseases.
- Some mtDNA mutations may confer longevity benefits by reducing oxidative stress.
Purpose of the Study:
- To investigate aging-related variations in the entire mitochondrial genome within the Turkish population.
- To identify specific mtDNA mutations and haplotypes associated with longevity.
Main Methods:
- Whole mitochondrial DNA re-sequencing of 50 individuals (nonagenarians and controls).
- Comparative analysis of single nucleotide polymorphism (SNP) frequencies, SNP effects, SNP accumulation in mtDNA regions, and haplotype profiles.
- Statistical evaluation of observed variations between elderly and control groups.
Main Results:
- Significantly higher total mitochondrial SNP frequency in nonagenarians compared to controls.
- Increased prevalence of non-coding, synonymous, and tRNA mutations in the 90+ group.
- Specific polymorphisms (A73G, C152T) associated with longevity; a novel ATPase6 gene transversion (C8899A) negatively associated with longevity.
- Accumulation of mutations in the D-loop region and Complex I genes; increased non-synonymous mutations in Complex I genes in aged subjects.
- Haplotype H was more prevalent in the control group.
Conclusions:
- Mitochondrial genome variations play a role in human longevity.
- The functionality of oxidative phosphorylation is linked to aging and lifespan.
- This study provides the first comprehensive whole mtDNA sequencing for the Turkish population.
Related Concept Videos
Animal Mitochondrial Genetics
7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Mitochondria
13.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Replication in Eukaryotes
15.4K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
15.4K
Telomeres and Telomerase
6.4K
6.4K


